These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24223710)

  • 1. Is the United States still dominant in the global pharmaceutical innovation network?
    Hu Y; Scherngell T; Man SN; Wang Y
    PLoS One; 2013; 8(11):e77247. PubMed ID: 24223710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents.
    Jiang Q; Luan C
    Global Health; 2018 Aug; 14(1):92. PubMed ID: 30165885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American export control, technology spillover and innovation of Chinese pharmaceutical Industry.
    Hui J
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1151-1155. PubMed ID: 28671099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COMPARISON OF 2 BILLS ON PHARMACEUTICAL PATENTING IN ITALY, THE EUROPEAN PATENT BILL AND THE GERMAN, ENGLISH AND UNITED STATES LAWS ON PATENTS OF INVENTIONS].
    BELLENGHI M
    Farmaco Prat; 1964 May; 19():240-51. PubMed ID: 14167551
    [No Abstract]   [Full Text] [Related]  

  • 6. Obstacles and opportunities in Chinese pharmaceutical innovation.
    Ni J; Zhao J; Ung CO; Hu Y; Hu H; Wang Y
    Global Health; 2017 Mar; 13(1):21. PubMed ID: 28340579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of Asian biopharmaceutical innovation.
    Friedman Y
    Nat Biotechnol; 2014 Jun; 32(6):523-4. PubMed ID: 24911491
    [No Abstract]   [Full Text] [Related]  

  • 8. US pharmaceutical innovation in an international context.
    Keyhani S; Wang S; Hebert P; Carpenter D; Anderson G
    Am J Public Health; 2010 Jun; 100(6):1075-80. PubMed ID: 20403883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of patent innovation in the field of brachytherapy.
    Miljanic M; Prabhu AV; Patel M; Lewis GD; Kim T
    Brachytherapy; 2020; 19(4):510-517. PubMed ID: 32249181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The shifting functional balance of patents and drug regulation.
    Eisenberg RS
    Health Aff (Millwood); 2001; 20(5):119-35. PubMed ID: 11558697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation.
    Dhulap S; Kulkarni M
    Pharm Pat Anal; 2019 Jul; 8(4):91-107. PubMed ID: 31414965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PCAST report on pharmaceutical innovation: implications for the FDA.
    Woodcock J
    Clin Pharmacol Ther; 2013 Sep; 94(3):297-300. PubMed ID: 23963215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Patent Landscape of RNAi-based Innovation for Plant Breeding.
    Frisio DG; Ventura V
    Recent Pat Biotechnol; 2019; 13(3):207-216. PubMed ID: 30714536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Innovation in pharmaceutical and health biotechnology industries: challenges for a virtuous agenda].
    Vargas M; Gadelha CA; Costa LS; Maldonado J
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():37-40. PubMed ID: 23532311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of nurse-authored patents: Implications for nursing practice.
    Davis CR; Glasgow MES
    Nurs Forum; 2020 Nov; 55(4):772-781. PubMed ID: 32851679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from 60 years of pharmaceutical innovation.
    Munos B
    Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discussions on the new molecular formula and new molecular entity definitions of pharmaceutical innovation.
    Gupta M; Kannappan S
    Pharm Pat Anal; 2018 Nov; 7(6):235-239. PubMed ID: 30657413
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
    Kesselheim AS
    AAPS J; 2007 Aug; 9(3):E306-11. PubMed ID: 17915832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of external innovation on new drug approvals: A retrospective analysis.
    Liu X; Thomas CE; Felder CC
    Int J Pharm; 2019 May; 563():273-281. PubMed ID: 30664998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.